Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/6788
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAtkins, G.en
dc.contributor.authorHaynes, D.en
dc.contributor.authorGraves, S.en
dc.contributor.authorEvdokiou, A.en
dc.contributor.authorHay, S.en
dc.contributor.authorBouralexis, S.en
dc.contributor.authorFindlay, D.en
dc.date.issued2000en
dc.identifier.citationJournal of Bone and Mineral Research, 2000; 15(4):640-649en
dc.identifier.issn0884-0431en
dc.identifier.issn1523-4681en
dc.identifier.urihttp://hdl.handle.net/2440/6788-
dc.description.abstractThe mechanisms by which primary tumors of the bone cause bone destruction have not been elucidated. Unlike most other lytic bone tumors, osteoclastomas, otherwise known as giant cell tumors (GCT), contain osteoclast-like cells within the tumor stroma. A new member of the TNF-ligand superfamily member, osteoclast differentiation factor (ODF/OPGL/RANKL/TRANCE), was recently identified. ODF was shown to directly stimulate osteoclastogenesis, in the presence of M-CSF. In this study, the expression of ODF was examined in a number of tumor samples associated with bone lysis in vivo. In addition, we investigated expression of the ODF receptor on osteoclast precursors, RANK, as well as the ODF inhibitor osteoprotegerin (OPG), and another TNF-ligand superfamily member, TRAIL, previously shown to abrogate the inhibitory effects of OPG. We report here the novel finding that GCT stromal cells contain abundant ODF mRNA, whereas the giant cell population exclusively expresses RANK mRNA. These results are consistent with the osteoclast-mediated bone destruction by these tumors. We also report the expression of OPG and TRAIL mRNA in GCT samples. A comparison with other lytic and nonlytic tumors of bone showed that GCT express more ODF and TRAIL mRNA relative to OPG mRNA. In addition, GCT were found to express a number of cytokines previously reported to play central roles in osteoclastogenesis, namely, IL-1, -6, -11, -17, as well as TNF-alpha. Importantly, GCT were also found to express high levels of M-CSF mRNA, a cytokine shown to be an essential cofactor of ODF, and a survival factor for mature and developing osteoclasts. Furthermore, expression of these molecules by stromal cells isolated from GCT continued in vitro. Thus GCT constitutively express all of the signals that are currently understood to be necessary for the differentiation of osteoclasts from precursor cells.en
dc.language.isoenen
dc.publisherAmer Soc Bone & Mineral Resen
dc.subjectOsteoclasts; Giant Cell Tumor of Bone; Bone Neoplasms; Glycoproteins; Tumor Necrosis Factor-alpha; Carrier Proteins; Membrane Glycoproteins; Receptors, Tumor Necrosis Factor; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Biological Markers; Cytokines; Ligands; Signal Transduction; Cell Differentiation; Hematopoiesis; Gene Expression; Apoptosis Regulatory Proteins; RANK Ligand; TNF-Related Apoptosis-Inducing Ligand; Osteoprotegerinen
dc.titleExpression of osteoclast differentiation signals by stromal elements of giant cell tumorsen
dc.typeJournal articleen
dc.identifier.rmid0001001072en
dc.identifier.doi10.1359/jbmr.2000.15.4.640en
dc.identifier.pubid63405-
pubs.library.collectionOrthopaedics and Trauma publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidAtkins, G. [0000-0002-3123-9861]en
dc.identifier.orcidEvdokiou, A. [0000-0001-8321-9806]en
Appears in Collections:Orthopaedics and Trauma publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.